JPWO2021261931A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021261931A5 JPWO2021261931A5 JP2022579971A JP2022579971A JPWO2021261931A5 JP WO2021261931 A5 JPWO2021261931 A5 JP WO2021261931A5 JP 2022579971 A JP2022579971 A JP 2022579971A JP 2022579971 A JP2022579971 A JP 2022579971A JP WO2021261931 A5 JPWO2021261931 A5 JP WO2021261931A5
- Authority
- JP
- Japan
- Prior art keywords
- contained
- amount
- composition according
- eye
- eye drop
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims description 36
- 229920000136 polysorbate Polymers 0.000 claims description 8
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 5
- 235000004866 D-panthenol Nutrition 0.000 claims description 5
- 239000011703 D-panthenol Substances 0.000 claims description 5
- 229960003949 dexpanthenol Drugs 0.000 claims description 5
- 229920002675 Polyoxyl Polymers 0.000 claims description 2
- 239000004359 castor oil Substances 0.000 claims description 2
- 235000019438 castor oil Nutrition 0.000 claims description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 2
- 239000003889 eye drop Substances 0.000 claims 18
- 239000002202 Polyethylene glycol Substances 0.000 claims 8
- 229920001223 polyethylene glycol Polymers 0.000 claims 8
- NMLMACJWHPHKGR-NCOIDOBVSA-N P(1),P(4)-bis(uridin-5'-yl) tetraphosphate Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@H]2O)O)COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N2C(NC(=O)C=C2)=O)O)O)C=CC(=O)NC1=O NMLMACJWHPHKGR-NCOIDOBVSA-N 0.000 claims 7
- 229950003529 diquafosol Drugs 0.000 claims 7
- 229950008882 polysorbate Drugs 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 6
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 5
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 5
- 235000010493 xanthan gum Nutrition 0.000 claims 5
- 239000000230 xanthan gum Substances 0.000 claims 5
- 229920001285 xanthan gum Polymers 0.000 claims 5
- 229940082509 xanthan gum Drugs 0.000 claims 5
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 2
- 206010013774 Dry eye Diseases 0.000 claims 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 2
- 229940069328 povidone Drugs 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 1
- 239000006172 buffering agent Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000003002 pH adjusting agent Substances 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 239000004034 viscosity adjusting agent Substances 0.000 claims 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2020-0076573 | 2020-06-23 | ||
KR20200076573 | 2020-06-23 | ||
PCT/KR2021/007923 WO2021261931A1 (ko) | 2020-06-23 | 2021-06-23 | 디쿠아포솔을 포함하는 점안 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023531725A JP2023531725A (ja) | 2023-07-25 |
JPWO2021261931A5 true JPWO2021261931A5 (ko) | 2024-07-02 |
Family
ID=79178835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022579971A Pending JP2023531725A (ja) | 2020-06-23 | 2021-06-23 | ジクアホソルを含む点眼組成物 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2023531725A (ko) |
KR (3) | KR102365008B1 (ko) |
CN (1) | CN115701986A (ko) |
WO (2) | WO2021261931A1 (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114191378A (zh) * | 2021-11-23 | 2022-03-18 | 温州医科大学附属眼视光医院 | 一种地夸磷索缓释凝胶及其制备方法与应用 |
KR102689517B1 (ko) | 2023-10-26 | 2024-07-29 | 강현희 | 반려동물용 인공눈물의 조성물 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080139652A1 (en) * | 2003-11-07 | 2008-06-12 | Yusuke Sakai | Pharmaceutical Composition Containing Prostaglandin |
US7875271B2 (en) * | 2006-03-23 | 2011-01-25 | Senju Pharmaceutical Co., Ltd. | Ophthalmic composition comprising xanthan gum and glucose |
KR101726029B1 (ko) * | 2012-02-24 | 2017-04-11 | 보오슈 앤드 롬 인코포레이팃드 | 알콕실화된 천연 왁스를 갖는 안과용 조성물 |
RU2697844C9 (ru) * | 2014-11-25 | 2019-10-01 | Аллерган, Инк. | Стабилизированные композиции для офтальмологического применения, содержащие омега-3-кислоты |
TWI709405B (zh) | 2014-12-25 | 2020-11-11 | 日商參天製藥股份有限公司 | 水性點眼液及其應用 |
CA2987882A1 (en) * | 2015-06-05 | 2016-12-08 | Santen Pharmaceutical Co., Ltd. | Therapeutic agent for dry eye characterized by being applied to eye of dry eye patient wearing soft contact lens |
-
2021
- 2021-04-27 KR KR1020210054453A patent/KR102365008B1/ko active IP Right Grant
- 2021-06-23 KR KR1020210081832A patent/KR20210158355A/ko active Search and Examination
- 2021-06-23 CN CN202180045168.2A patent/CN115701986A/zh active Pending
- 2021-06-23 WO PCT/KR2021/007923 patent/WO2021261931A1/ko active Application Filing
- 2021-06-23 JP JP2022579971A patent/JP2023531725A/ja active Pending
- 2021-06-23 WO PCT/KR2021/007919 patent/WO2021261927A1/ko active Application Filing
-
2022
- 2022-02-15 KR KR1020220019446A patent/KR20220025775A/ko active Application Filing
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2437723B1 (en) | Omega-3 oil containing ophthalmic emulsions | |
KR101188156B1 (ko) | 콘택트렌즈용 안과용 조성물 | |
TWI489997B (zh) | 含有硼酸-多元醇錯合物之水性藥學組成物 | |
KR20130112728A (ko) | 방부제 없는 프로스타글란딘계 비점성 용액의 고분자 전달 시스템 | |
KR101820184B1 (ko) | 방부제가 없는 비마토프로스트 및 티몰롤 용액 | |
KR20190065237A (ko) | 안과용 제품 및 점도 저하 억제 방법 | |
KR101858590B1 (ko) | 안과용 조성물 | |
US20190008832A1 (en) | Compositions for the treatment of presbyopia | |
JP3142842B1 (ja) | 眼科用組成物及びソフトコンタクトレンズへの吸着抑制方法 | |
TW202031263A (zh) | 抑制軟性隱形眼鏡變質之眼科用組成物 | |
KR20220025775A (ko) | 디쿠아포솔을 포함하는 점안 조성물 | |
EP1283043B1 (en) | Ophthalmic solution | |
JP2022031430A (ja) | 眼科用製品及び粘度低下抑制方法 | |
JP2022548221A (ja) | シクロスポリンおよびメントール含有ナノエマルジョン点眼組成物およびその製造方法 | |
JPWO2021261931A5 (ko) | ||
CN106999452A (zh) | 前列腺素类和一氧化氮供体的组合产品 | |
CA2413088C (en) | Preservative | |
JP5713034B2 (ja) | 眼科用組成物、及び眼科製剤用防腐組成物 | |
CN110022856B (zh) | 用于降低眼压的眼用组合物 | |
JPWO2021261930A5 (ko) | ||
KR102444571B1 (ko) | 세티리진 및 토코페솔란을 포함하는 안과용 조성물 | |
RU2772230C2 (ru) | Композиция в форме глазных капель для снижения внутриглазного давления | |
AU2014250656B2 (en) | Omega-3 oil containing ophthalmic emulsions | |
KR20230092814A (ko) | 브린졸라미드 및 티몰롤을 함유하는 투명 복합점안제 | |
JP2023016966A (ja) | 眼科組成物 |